financetom
Business
financetom
/
Business
/
Shell Absorbs Charges, Pauses Project: Q2 Outlook Dims With Impairments and Biofuels Halt
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Shell Absorbs Charges, Pauses Project: Q2 Outlook Dims With Impairments and Biofuels Halt
Jul 5, 2024 3:36 AM

Shell plc ( SHEL ) shares are trading higher premarket today. The British energy company updated its operational outlook for the second quarter of FY24.

The company expects to incur non-cash post tax impairments of $1.5 – $2 billion in the quarter, including $0.6 billion – $0.8 billion in Singapore Chemicals & Products assets and $0.6 billion – $1.0 billion in Rotterdam HEFA assets.

Notably, this week, Shell stated that it is temporarily pausing construction at its 820,000 tonnes-per-year biofuels facility in Rotterdam to address project delivery and ensure future competitiveness amid current market conditions.

Outlook Revised: For Integrated Gas, the company updated the production outlook to be 940 – 980 thousand boe/d (vs. 920 – 980 thousand boe/d expected earlier) and LNG liquefaction volumes to 6.8 – 7.2 MT (vs. 6.8 – 7.4 MT prior).

Read: Shell Secures Major LNG Deal With Temasek’s Pavilion Energy: Details

The outlook reflects that Trading and optimisation results are expected to be in line with second-quarter FY23 but lower than first-quarter FY24 due to seasonality.

For Upstream, Shell narrowed production guidance to 1,720 – 1,820 thousand boe/d (vs. 1,630 – 1,830 thousand boe/d earlier), with shares of profit / (loss) of joint ventures and associates expected to be ~$0.2 billion and exploration well-write offs projected to be ~$0.2 billion.

For Marketing, the company lowered the high end of the sales volume guidance, with the revised range at 2,700 – 3,100 thousand b/d (vs. 2,700 – 3,200 projected earlier).

For Chemicals & Products, Shell currently sees refinery utilization of 91% – 95% (vs. 87% – 95% earlier), reflecting planned maintenance activities in North America and Chemicals utilization of 78% – 82% (vs. 72% – 80% prior).

The company projects Chemicals sub-segment adjusted earnings to be close to break-even in second-quarter FY24.

Shell stock has gained around 22% in the last 12 months. Investors can gain exposure to the stock via Direxion Hydrogen ETF ( HJEN ) and VanEck Natural Resources ETF ( HAP ) .

Also Read: Shell Pauses European Biofuels Facility Construction, Reviews Project Economics

Price Action: SHEL shares are up 1.21% at $73.89 premarket at the last check Friday.

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Image by siam.pukkato via Shutterstock

Read Next:

Shell’s Move Toward Net Zero Emissions – To Build Carbon Capture And Storage Project In Canada

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Corcept Therapeutics (CORT) Shares Fall Again Amid Report FDA Warned Several Times Not to Submit Relacorilant Drug Application – Hagens Berman
Corcept Therapeutics (CORT) Shares Fall Again Amid Report FDA Warned Several Times Not to Submit Relacorilant Drug Application – Hagens Berman
Mar 11, 2026
SAN FRANCISCO, Jan. 30, 2026 (GLOBE NEWSWIRE) -- The latest adverse development for Corcept Therapeutics ( CORT ) concerning its proposed treatment of patients with hypercortisolism (also known as Cushing’s syndrome) – relacorilant – came on January 30, 2026 when Reuters reported that the FDA “warned the company ‘on several occasions’ not to submit its drug application.” This news sent...
--Cincinnati Financial Increases Quarterly Dividend to $0.94 per Share From $0.87; Payable April 15 to Holders of Record March 24
--Cincinnati Financial Increases Quarterly Dividend to $0.94 per Share From $0.87; Payable April 15 to Holders of Record March 24
Mar 11, 2026
03:25 PM EST, 01/30/2026 (MT Newswires) -- Price: 160.06, Change: +1.87, Percent Change: +1.18 ...
Visa Delivers Fiscal Q1 Beat Despite Lower FX Volatility, Higher Marketing Spend, Oppenheimer Says
Visa Delivers Fiscal Q1 Beat Despite Lower FX Volatility, Higher Marketing Spend, Oppenheimer Says
Mar 11, 2026
11:22 AM EST, 01/30/2026 (MT Newswires) -- Visa (V) managed to deliver a fiscal Q1 beat even amid higher marketing spend and lower foreign exchange volatility, Oppenheimer said. Visa's operating expenses were slightly above expectations in the quarter. The investment firm said in a Thursday note that the company's Q2 operating expense growth guidance came in at the high end...
Eli Lilly Plans $3.5 Billion Facility in Pennsylvania to Develop New Weight-Loss Drugs
Eli Lilly Plans $3.5 Billion Facility in Pennsylvania to Develop New Weight-Loss Drugs
Mar 11, 2026
03:16 PM EST, 01/30/2026 (MT Newswires) -- Eli Lilly ( LLY ) said Friday it intends to invest more than $3.5 billion in a new facility in Pennsylvania as part of its commitment to boost drug production in the US. The planned site in the Lehigh Valley will serve as the company's latest injectable medicine and device making facility that...
Copyright 2023-2026 - www.financetom.com All Rights Reserved